Trials / Completed
CompletedNCT02766907
Optimizing the Ocular Surface Prior to Cataract Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- BioTissue Holdings, Inc · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Prospective study to evaluate the efficacy of using self-retained cryopreserved amniotic membrane after debridement in treating Epithelial Base Membrane Dystrophy (EBMD) to optimize the ocular surface integrity and intraocular lens calculation before cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cryopreserved amniotic membrane | placement of cryopreserved amniotic membrane after routine debridement procedure for EBMD |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-01-01
- Completion
- 2018-04-01
- First posted
- 2016-05-10
- Last updated
- 2019-03-19
- Results posted
- 2019-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02766907. Inclusion in this directory is not an endorsement.